Cargando…

Therapeutic Strategies against Leishmania and Trypanosoma

Detalles Bibliográficos
Autores principales:	Santos, André L. S., Rodrigues, Igor A., d’Avila-Levy, Claudia M., Sodré, Cátia L., Ritmeijer, Koert, Branquinha, Marta H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610452/ https://www.ncbi.nlm.nih.gov/pubmed/37887779 http://dx.doi.org/10.3390/pathogens12101263

Ejemplares similares

Repositioning drug strategy against Trypanosoma cruzi: lessons learned from HIV aspartyl peptidase inhibitors
por: Sangenito, Leandro Stefano, et al.
Publicado: (2022)

MDL28170, a Calpain Inhibitor, Affects Trypanosoma cruzi Metacyclogenesis, Ultrastructure and Attachment to Rhodnius prolixus Midgut
por: Ennes-Vidal, Vítor, et al.
Publicado: (2011)

Miltefosine-Lopinavir Combination Therapy Against Leishmania infantum Infection: In vitro and in vivo Approaches
por: Rebello, Karina M., et al.
Publicado: (2019)

Nelfinavir is effective in inhibiting the multiplication and aspartic peptidase activity of Leishmania species, including strains obtained from HIV-positive patients
por: Santos, Lívia O., et al.
Publicado: (2013)

Decoding the Anti-Trypanosoma cruzi Action of HIV Peptidase Inhibitors Using Epimastigotes as a Model
por: Sangenito, Leandro S., et al.
Publicado: (2014)

Expression and cellular localisation of Trypanosoma cruzi calpains
por: Ennes-Vidal, Vítor, et al.
Publicado: (2020)

Participation of Trypanosoma cruzi gp63 molecules on the interaction with Rhodnius prolixus
por: Rebello, Karina M., et al.
Publicado: (2019)

Cruzipain Promotes Trypanosoma cruzi Adhesion to Rhodnius prolixus Midgut
por: Uehara, Lívia Almeida, et al.
Publicado: (2012)

HIV Aspartyl Peptidase Inhibitors Interfere with Cellular Proliferation, Ultrastructure and Macrophage Infection of Leishmania amazonensis
por: Santos, Lívia O., et al.
Publicado: (2009)

Calpains of Leishmania braziliensis: genome analysis, differential expression, and functional analysis
por: Ennes-Vidal, Vítor, et al.
Publicado: (2019)

Docking simulation between HIV peptidase inhibitors and Trypanosoma cruzi aspartyl peptidase
por: Castilho, Vanessa V. S., et al.
Publicado: (2018)

Differences in Charge Distribution in Leishmania tarentolae Leishmanolysin Result in a Reduced Enzymatic Activity
por: Ennes-Vidal, Vítor, et al.
Publicado: (2022)

Chagas Disease Control—Many Approaches to Prospect
por: Branquinha, Marta H., et al.
Publicado: (2023)

Why calpain inhibitors are interesting leading compounds to search for new therapeutic options to treat leishmaniasis?
por: ENNES-VIDAL, VITOR, et al.
Publicado: (2017)

Aspartic Peptidases of Human Pathogenic Trypanosomatids: Perspectives and Trends for Chemotherapy
por: Santos, L.O., et al.
Publicado: (2013)

Lopinavir, an HIV-1 peptidase inhibitor, induces alteration on the lipid metabolism of Leishmania amazonensis promastigotes
por: Rebello, Karina M., et al.
Publicado: (2018)

The Calpain Inhibitor MDL28170 Induces the Expression of Apoptotic Markers in Leishmania amazonensis Promastigotes
por: Marinho, Fernanda A., et al.
Publicado: (2014)

The Diverse Calpain Family in Trypanosomatidae: Functional Proteins Devoid of Proteolytic Activity?
por: Ennes-Vidal, Vítor, et al.
Publicado: (2021)

Proteolytic inhibitors as alternative medicines to treat trypanosomatid-caused diseases: experience with calpain inhibitors
por: Ennes-Vidal, Vítor, et al.
Publicado: (2022)

Antileishmanial activity of MDL 28170, a potent calpain inhibitor
por: d’Avila-Levy, Claudia M., et al.
Publicado: (2006)

The Anti-Leishmania amazonensis and Anti-Leishmania chagasi Action of Copper(II) and Silver(I) 1,10-Phenanthroline-5,6-dione Coordination Compounds
por: Oliveira, Simone S. C., et al.
Publicado: (2023)

In Vitro Effects of Aminopyridyl Ligands Complexed to Copper(II) on the Physiology and Interaction Process of Trypanosoma cruzi
por: Silva-Oliveira, Rafaela, et al.
Publicado: (2023)

Silver(I) and Copper(II) 1,10-Phenanthroline-5,6-dione Complexes as Promising Antivirulence Strategy against Leishmania: Focus on Gp63 (Leishmanolysin)
por: Oliveira, Simone S. C., et al.
Publicado: (2023)

Antileishmanial Efficacy of the Calpain Inhibitor MDL28170 in Combination with Amphotericin B
por: Branquinha, Marta H., et al.
Publicado: (2022)

Expression of calpain-like proteins and effects of calpain inhibitors on the growth rate of Angomonas deanei wild type and aposymbiotic strains
por: de Oliveira, Simone Santiago Carvalho, et al.
Publicado: (2015)

The Enhanced Expression of Cruzipain-Like Molecules in the Phytoflagellate Phytomonas serpens Recovered From the Invertebrate and Plant Hosts
por: Oliveira, Simone S. C., et al.
Publicado: (2022)

Lopinavir and Nelfinavir Induce the Accumulation of Crystalloid Lipid Inclusions within the Reservosomes of Trypanosoma cruzi and Inhibit Both Aspartyl-Type Peptidase and Cruzipain Activities Detected in These Crucial Organelles
por: Sangenito, Leandro S., et al.
Publicado: (2021)

Calpains: Potential Targets for Alternative Chemotherapeutic Intervention Against Human Pathogenic Trypanosomatids
por: M.H, Branquinha, et al.
Publicado: (2013)

Overview of DNA Repair in Trypanosoma cruzi, Trypanosoma brucei, and Leishmania major
por: Passos-Silva, Danielle Gomes, et al.
Publicado: (2010)

A Stroll Through the History of Monoxenous Trypanosomatids Infection in Vertebrate Hosts
por: Boucinha, Carolina, et al.
Publicado: (2022)

Analysis of Peptidases in Non-Infected and Trypanosoma cruzi-Infected Mouse Embryo Hepatocyte Cells
por: de Melo, Ana Cristina Nogueira, et al.
Publicado: (2008)

Cytotoxicity of Essential Oil Cordia verbenaceae against Leishmania brasiliensis and Trypanosoma cruzi
por: Pereira, Pedro S., et al.
Publicado: (2021)

Activity of Compounds from Temperate Propolis against Trypanosoma brucei and Leishmania mexicana
por: Alotaibi, Adullah, et al.
Publicado: (2021)

Activity of Estafietin and Analogues on Trypanosoma cruzi and Leishmania braziliensis
por: Sülsen, Valeria P., et al.
Publicado: (2019)

Cellular landmarks of Trypanosoma brucei and Leishmania mexicana
por: Halliday, Clare, et al.
Publicado: (2019)

P-type transport ATPases in Leishmania and Trypanosoma
por: Meade, John C.
Publicado: (2019)

Effects of Structurally Different HDAC Inhibitors against Trypanosoma cruzi, Leishmania, and Schistosoma mansoni
por: Di Bello, Elisabetta, et al.
Publicado: (2022)

Failure of an Innovative Low-Cost, Noninvasive Thermotherapy Device for Treating Cutaneous Leishmaniasis Caused by Leishmania tropica in Pakistan
por: Kämink, Suzette, et al.
Publicado: (2019)

Proteins and lipids of glycosomal membranes from Leishmania tarentolae and Trypanosoma brucei
por: Colasante, Claudia, et al.
Publicado: (2013)

Analysing ambiguities in trypanosomatids taxonomy by barcoding
por: Boucinha, Carolina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ue9u60ic3ogavjasn1j7t8s1eg